Industry is beginning to accept that allogeneic cell therapy spans categories, and success depends on aligning biology, regulation, and economics unique to each product.
- Building CGT Manufacturing Capacity For The Next Commercial Era
- Managing The Presence Of Visible Particulates In Cell Therapies
- FDA Approval Of TREGZI Signals A New Era For Precision Engineered Cell Therapy
- Analyzing And Managing CDMO Project Risks Using Causal Mechanism & Effect Analysis
- Achieving Annex 1 Compliance In Sterile Manufacturing, Part 3: Building A Compliant Program
- Wondering If Your Org Should Purchase R&D Datasets?
- Mapping Early-Phase Supply Chain Bottlenecks That Doom Pipelines
- Achieving Annex 1 Compliance In Sterile Manufacturing, Part 2: Objective Measurement Tools
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-508496956-dna]( "Streamlining Data For Efficient Therapeutic Manufacturing")
Streamlining Data For Efficient Therapeutic ManufacturingAn integrated solution for impurity and sterility analysis streamlines data, supports regulatory compliance, and uses built-in algorithms to deliver accurate, actionable results quickly.
-
![GettyImages-597972428-adenovirus]( "Development Strategies For Adenovirus-Based Gene Therapies")
Development Strategies For Adenovirus-Based Gene TherapiesScaling up viral vector production can be challenging, and ensuring consistent titers and activity requires careful optimization and technical expertise.
-
![Fragment-Analyzer_Agilent_0544_screen]( "Preventive Control Of Sequencing Through The Insert")
Preventive Control Of Sequencing Through The InsertUnderstanding library size distributions helps prevent sequencing through the insert, reducing adapter read‑through. Explore how smear analysis guides optimal read‑length selection to avoid noise.
-
![Corning - closed system]( "How To Take Your Process To A Closed System")
How To Take Your Process To A Closed SystemUnderstand the critical considerations for implementing closed systems in bioproduction, from vessel selection to workflow customization for optimal efficiency and safety.
-
![Global logistics supply chain-GettyImages-2256982707]( "An Innovative, Modular Approach To Flexible Supply Chain Management")
An Innovative, Modular Approach To Flexible Supply Chain ManagementLearn how modular strategies, global coordination, and data-driven decisions help maintain continuity, compliance, and speed amid constant uncertainty.
-
![GettyImages-1299489003-- frozen--vaccine]( "Direct Inoculation From Cryopreserved Cell Banks Using An Automated FBR")
Direct Inoculation From Cryopreserved Cell Banks Using An Automated FBRDirectly inoculated your HEK293 cells into the bioreactor from cryopreservation vials or bags just using this fixed bed bioreactor (FBR) system's automated process steps.
-
![Thermo - DynaSpin]( "Finding An Optimal Harvest Solution By Considering Both Cost And Sustainability")
Finding An Optimal Harvest Solution By Considering Both Cost And SustainabilityOptimize your bioprocessing harvest with single-use centrifugation. Reduce costs, waste, and space needs compared to traditional depth filtration methods.
-
![GettyImages-1935725164-disease-cell-blue]( "3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived Neurons")
3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived NeuronsExplore how different ApoE alleles influence Alzheimer's Disease risk using iPSC-derived neurons as well as gain insights into AD mechanisms and potential therapies.
-
![GettyImages-1435391920-cell-culture-development-well-plate]( "Integrating Cutting-Edge Technologies In Cell Bank Manufacturing")
Integrating Cutting-Edge Technologies In Cell Bank ManufacturingDiscover how our adoption of a counterflow centrifuge enhances GMP-compliant cell banking through closed-system automation, precision harvesting, and scalable workflows.
-
![GettyImages-2150753936 cancer cell]( "Anticoagulant Selection Influences T Cell Purity And Yield In Whole Blood Isolation")
Anticoagulant Selection Influences T Cell Purity And Yield In Whole Blood IsolationLithium heparin reduces T cell purity to below 50% and spikes CD15+ contamination in whole blood workflows. See which anticoagulants consistently deliver above 90% CD3+ purity.
NEWSLETTER ARCHIVE
- 07.14.26 -- STREAM Edition: The Facility Master Planning Playbook With Herman Bozenhardt
- 07.14.26 -- Advancing Autologous Stem Cell Engineering For Diabetes And Vision Loss
- 07.13.26 -- Practical Strategies for Contamination Control and EM Compliance
- 07.13.26 -- How CGT Developers Should Think About Manufacturing Models, Hybrid Strategies, And Scale
- 07.11.26 -- Cell & Gene Newsletter - Best Of June
- FDA Approval Of TREGZI Signals A New Era For Precision Engineered Cell Therapy
- How CGT Developers Should Think About Manufacturing Models, Hybrid Strategies, And Scale
- In Vivo Gene Editing Is Moving From Promise To Proof
- Driving Gene Therapy Beyond Rare Disease Will Define The Next Era Of CGT
- CGT Manufacturing Shifts From Capacity To Strategy
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
